rybelsus
Rybelsus - Oral Treatment for Diabetes and Obesity
Rybelsus is an oral medication used for treating diabetes. It works by mimicking the activity of the GLP-1 hormone, which helps regulate blood sugar levels. With special approval, Rybelsus can also be prescribed for weight loss, assisting in reducing weight by slowing stomach emptying after meals and significantly increasing feelings of fullness.
- Age 18 and above.
- BMI of 30 or higher (defined as severe obesity).
- BMI of 27 or higher (defined as overweight), provided there is at least one additional obesity-related risk factor, such as diabetes, high blood pressure, elevated blood lipid levels, etc.
איך ריבלסוס פועלת בגוף?
Rybelsus is a medication based on a molecule structurally similar to the human hormone GLP-1. In other words, it’s a synthetic derivative of this hormone, capable of mimicking its natural functions in the body, placing it in the drug class known as “Incretin Mimetics”. GLP-1 is a hormone secreted in the digestive tract following meals.
One of its roles in the body is to stimulate insulin secretion from pancreatic beta cells, thereby helping to regulate blood sugar levels. Additionally, this hormone enhances feelings of fullness after eating. As for Rybelsus specifically, the medication appears to aid weight loss by influencing areas of the brain that slow stomach emptying after meals and significantly increase sensations of satiety.

אילו מחקרים התבצעו על ריבלסוס?
Although Rybelsus is not officially approved as a weight-loss medication, many patients who previously took it for diabetes management also experienced weight loss. For instance, studies have shown that patients taking Rybelsus (active ingredient: semaglutide) at a dosage of 3.7 mg lost an average of 2.3 kg. In contrast, patients on Rybelsus at a higher dosage of 14 mg lost approximately 3.7 kg.
However, compared to these earlier studies, a recent clinical trial highlighted the potential of the active ingredient in Rybelsus (semaglutide) to help individuals with obesity reduce their body weight by an impressive 10-15%. These significant weight reductions could potentially lower the risk of developing severe chronic diseases.
The trial included 1,961 adults with a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 with at least one obesity-related risk factor. None of the participants had diabetes, though some were diagnosed with prediabetes at the start of the study. All participants received dietary counseling and a recommendation to engage in 150 minutes of physical activity per week.
Participants who took a higher dosage of semaglutide (the active ingredient in Rybelsus), administered weekly at 2.4 mg via injection, in combination with dietary modifications and exercise, lost approximately 15 kg by the end of 68 weeks. In comparison, those who received a placebo lost only around 2.6 kg.

The group taking the medication also experienced significantly greater improvements in obesity-related health conditions and reductions in waist circumference. Safety profiles were excellent, and side effects in both groups were mild and comparable to the placebo group.
Furthermore, a meta-analysis conducted in January 2021 reviewed several recent clinical studies comparing the weight-loss efficacy of semaglutide (the active ingredient in Rybelsus) to other weight-loss medications. To specifically isolate the effect of each medication on weight loss, researchers subtracted the weight loss observed in placebo groups from that seen in participants who took the medication.
The findings revealed that the medication Qsymia resulted in an average weight loss of 6.8% of body weight; Saxenda led to an average reduction of 5.4%; Contrave contributed to a 4% average weight loss, and Xenical resulted in a 2.9% reduction on average. In comparison, patients taking semaglutide (the active ingredient in Rybelsus, Wegovy, and Ozempic) lost an impressive 12.4% of their body weight on average.

The Multidisciplinary Approach to Obesity Treatment
The most effective method for weight loss through medication is a personalized treatment plan, supported and monitored by a multidisciplinary team of experts.
Various clinical studies \[4,5] conducted in recent years have shown that the most successful approach to weight loss combines individually tailored medications at adjustable dosages, including medication combinations, with medical supervision and ongoing nutritional follow-up by a clinical dietitian within a structured treatment framework. This process significantly improves patient adherence and supports long-term weight maintenance.
The Obesity Treatment Center offers a comprehensive multidisciplinary weight loss program combined with medication-based treatment. This program includes:
Combined Treatment
Personal Guidance
Diagnosis
Personal Follow-Up
Reducing Side Effects
Continuity of Care
Personally Guided Nutritional Program
Lifestyle Habits
טבלת קליקים וויגובי - כל המינונים
Wegovy 0.25mg
| Wegovy 0.25mg | |
| מינון | קליק |
| 0.006 | 1 |
| 0.013 | 2 |
| 0.02 | 3 |
| 0.027 | 4 |
| 0.033 | 5 |
| 0.04 | 6 |
| 0.047 | 7 |
| 0.054 | 8 |
| 0.06 | 9 |
| 0.067 | 10 |
| 0.074 | 11 |
| 0.081 | 12 |
| 0.087 | 13 |
| 0.094 | 14 |
| 0.1 | 15 |
| 0.108 | 16 |
| 0.114 | 17 |
| 0.121 | 18 |
| 0.128 | 19 |
| 0.135 | 20 |
| 0.141 | 21 |
| 0.148 | 22 |
| 0.155 | 23 |
| 0.168 | 24 |
| 0.168 | 25 |
| 0.175 | 26 |
| 0.182 | 27 |
| 0.189 | 28 |
| 0.195 | 29 |
| 0.202 | 30 |
| 0.209 | 31 |
| 0.216 | 32 |
| 0.222 | 33 |
| 0.229 | 34 |
| 0.236 | 35 |
| 0.243 | 36 |
| 0.25 | 37 |
Wegovy 0.5mg
| Wegovy 0.5mg | |
| מינון | קליק |
| 0.0135 | 1 |
| 0.027 | 2 |
| 0.0405 | 3 |
| 0.0541 | 4 |
| 0.0676 | 5 |
| 0.0811 | 6 |
| 0.0946 | 7 |
| 0.1081 | 8 |
| 0.1216 | 9 |
| 0.1351 | 10 |
| 0.1486 | 11 |
| 0.1622 | 12 |
| 0.1757 | 13 |
| 0.1892 | 14 |
| 0.2027 | 15 |
| 0.2162 | 16 |
| 0.2297 | 17 |
| 0.2432 | 18 |
| 0.2568 | 19 |
| 0.2703 | 20 |
| 0.2838 | 21 |
| 0.2973 | 22 |
| 0.3108 | 23 |
| 0.3243 | 24 |
| 0.3378 | 25 |
| 0.3514 | 26 |
| 0.3649 | 27 |
| 0.3784 | 28 |
| 0.391 | 29 |
| 0.405 | 30 |
| 0.418 | 31 |
| 0.432 | 32 |
| 0.445 | 33 |
| 0.459 | 34 |
| 0.472 | 35 |
| 0.486 | 36 |
| 0.5 | 37 |
Wegovy 1mg
| Wegovy 1mg | |
| מינון | קליק |
| 0.013 | 1 |
| 0.026 | 2 |
| 0.04 | 3 |
| 0.053 | 4 |
| 0.066 | 5 |
| 0.08 | 6 |
| 0.093 | 7 |
| 0.106 | 8 |
| 0.12 | 9 |
| 0.133 | 10 |
| 0.146 | 11 |
| 0.16 | 12 |
| 0.173 | 13 |
| 0.186 | 14 |
| 0.2 | 15 |
| 0.213 | 16 |
| 0.226 | 17 |
| 0.24 | 18 |
| 0.253 | 19 |
| 0.266 | 20 |
| 0.28 | 21 |
| 0.293 | 22 |
| 0.306 | 23 |
| 0.32 | 24 |
| 0.333 | 25 |
| 0.346 | 26 |
| 0.36 | 27 |
| 0.373 | 28 |
| 0.386 | 29 |
| 0.4 | 30 |
| 0.413 | 31 |
| 0.426 | 32 |
| 0.44 | 33 |
| 0.453 | 34 |
| 0.466 | 35 |
| 0.48 | 36 |
| 0.493 | 37 |
| 0.506 | 38 |
| 0.52 | 39 |
| 0.533 | 40 |
| 0.546 | 41 |
| 0.56 | 42 |
| 0.573 | 43 |
| 0.586 | 44 |
| 0.6 | 45 |
| 0.613 | 46 |
| 0.626 | 47 |
| 0.64 | 48 |
| 0.653 | 49 |
| 0.666 | 50 |
| 0.693 | 51 |
| 0.693 | 52 |
| 0.706 | 53 |
| 0.72 | 54 |
| 0.733 | 55 |
| 0.746 | 56 |
| 0.76 | 57 |
| 0.773 | 58 |
| 0.786 | 59 |
| 0.8 | 60 |
| 0.813 | 61 |
| 0.826 | 62 |
| 0.84 | 63 |
| 0.853 | 64 |
| 0.866 | 65 |
| 0.88 | 66 |
| 0.893 | 67 |
| 0.906 | 68 |
| 0.92 | 69 |
| 0.933 | 70 |
| 0.946 | 71 |
| 0.96 | 72 |
| 0.973 | 73 |
| 0.986 | 74 |
| 1 | 75 |
Wegovy 1.7mg
| Wegovy 1.7mg | |
| מינון | קליק |
| 0.022 | 1 |
| 0.045 | 2 |
| 0.068 | 3 |
| 0.09 | 4 |
| 0.113 | 5 |
| 0.136 | 6 |
| 0.158 | 7 |
| 0.181 | 8 |
| 0.204 | 9 |
| 0.226 | 10 |
| 0.249 | 11 |
| 0.272 | 12 |
| 0.294 | 13 |
| 0.317 | 14 |
| 0.34 | 15 |
| 0.362 | 16 |
| 0.385 | 17 |
| 0.408 | 18 |
| 0.43 | 19 |
| 0.453 | 20 |
| 0.476 | 21 |
| 0.498 | 22 |
| 0.521 | 23 |
| 0.544 | 24 |
| 0.566 | 25 |
| 0.589 | 26 |
| 0.612 | 27 |
| 0.634 | 28 |
| 0.657 | 29 |
| 0.68 | 30 |
| 0.702 | 31 |
| 0.725 | 32 |
| 0.748 | 33 |
| 0.77 | 34 |
| 0.793 | 35 |
| 0.816 | 36 |
| 0.838 | 37 |
| 0.861 | 38 |
| 0.884 | 39 |
| 0.906 | 40 |
| 0.929 | 41 |
| 0.952 | 42 |
| 0.974 | 43 |
| 0.997 | 44 |
| 1.02 | 45 |
| 1.04 | 46 |
| 1.065 | 47 |
| 1.088 | 48 |
| 1.11 | 49 |
| 1.133 | 50 |
| 1.156 | 51 |
| 1.178 | 52 |
| 1.201 | 53 |
| 1.224 | 54 |
| 1.246 | 55 |
| 1.269 | 56 |
| 1.292 | 57 |
| 1.314 | 58 |
| 1.337 | 59 |
| 1.36 | 60 |
| 1.382 | 61 |
| 1.405 | 62 |
| 1.428 | 63 |
| 1.45 | 64 |
| 1.473 | 65 |
| 1.496 | 66 |
| 1.518 | 67 |
| 1.541 | 68 |
| 1.564 | 69 |
| 1.586 | 70 |
| 1.609 | 71 |
| 1.632 | 72 |
| 1.654 | 73 |
| 1.677 | 74 |
| 1.7 | 75 |
Wegovy 2.4mg
| Wegovy 2.4mg | |
| מינון | קליק |
| 0.032 | 1 |
| 0.064 | 2 |
| 0.096 | 3 |
| 0.128 | 4 |
| 0.16 | 5 |
| 0.192 | 6 |
| 0.224 | 7 |
| 0.256 | 8 |
| 0.288 | 9 |
| 0.32 | 10 |
| 0.352 | 11 |
| 0.384 | 12 |
| 0.416 | 13 |
| 0.448 | 14 |
| 0.48 | 15 |
| 0.512 | 16 |
| 0.544 | 17 |
| 0.576 | 18 |
| 0.608 | 19 |
| 0.64 | 20 |
| 0.672 | 21 |
| 0.704 | 22 |
| 0.736 | 23 |
| 0.768 | 24 |
| 0.8 | 25 |
| 0.832 | 26 |
| 0.864 | 27 |
| 0.896 | 28 |
| 0.928 | 29 |
| 0.96 | 30 |
| 0.992 | 31 |
| 1.024 | 32 |
| 1.056 | 33 |
| 1.088 | 34 |
| 1.12 | 35 |
| 1.152 | 36 |
| 1.184 | 37 |
| 1.216 | 38 |
| 1.248 | 39 |
| 1.28 | 40 |
| 1.312 | 41 |
| 1.344 | 42 |
| 1.376 | 43 |
| 1.408 | 44 |
| 1.44 | 45 |
| 1.472 | 46 |
| 1.504 | 47 |
| 1.536 | 48 |
| 1.568 | 49 |
| 1.6 | 50 |
| 1.632 | 51 |
| 1.664 | 52 |
| 1.696 | 53 |
| 1.728 | 54 |
| 1.76 | 55 |
| 1.792 | 56 |
| 1.824 | 57 |
| 1.856 | 58 |
| 1.888 | 59 |
| 1.92 | 60 |
| 1.952 | 61 |
| 1.984 | 62 |
| 2.016 | 63 |
| 2.048 | 64 |
| 2.08 | 65 |
| 2.112 | 66 |
| 2.144 | 67 |
| 2.176 | 68 |
| 2.208 | 69 |
| 2.24 | 70 |
| 2.272 | 71 |
| 2.304 | 72 |
| 2.336 | 73 |
| 2.368 | 74 |
| 2.4 | 75 |
מונג'רו / מאונג'רו טבלת קליקים - מינונים
Mounjaro 2.5mg
| מונג’רו 2.5mg | |
| מינון | קליק |
| 0.0417 | 1 |
| 0.0833 | 2 |
| 0.125 | 3 |
| 0.1667 | 4 |
| 0.2083 | 5 |
| 0.25 | 6 |
| 0.2917 | 7 |
| 0.3333 | 8 |
| 0.375 | 9 |
| 0.4167 | 10 |
| 0.5 | 12 |
| 0.625 | 15 |
| 0.75 | 18 |
| 0.8333 | 20 |
| 1 | 24 |
| 1.25 | 30 |
| 1.5 | 36 |
| 1.6667 | 40 |
| 2 | 48 |
| 2.5 | 60 |
Mounjaro 5mg
| מונג’רו 5mg | |
| קליק | מינון |
| 1 | 0.0833 |
| 2 | 0.1667 |
| 3 | 0.25 |
| 4 | 0.3333 |
| 5 | 0.4167 |
| 6 | 0.5 |
| 7 | 0.5833 |
| 8 | 0.6667 |
| 9 | 0.75 |
| 10 | 0.8333 |
| 12 | 1 |
| 15 | 1.25 |
| 18 | 1.5 |
| 20 | 1.6667 |
| 24 | 2 |
| 30 | 2.5 |
| 36 | 3 |
| 40 | 3.3333 |
| 48 | 4 |
| 60 | 5 |
Mounjaro 15mg
| מונג’רו 15mg | |
| קליק | מינון |
| 1 | 0.25 |
| 2 | 0.5 |
| 3 | 0.75 |
| 4 | 1 |
| 5 | 1.25 |
| 6 | 1.5 |
| 7 | 1.75 |
| 8 | 2 |
| 9 | 2.25 |
| 10 | 2.5 |
| 12 | 3 |
| 15 | 3.75 |
| 18 | 4.5 |
| 20 | 5 |
| 24 | 6 |
| 30 | 7.5 |
| 36 | 9 |
| 40 | 10 |
| 48 | 12 |
| 60 | 15 |
Mounjaro 7.5mg
| מונג’רו 7.5mg | |
| קליק | מינון |
| 1 | 0.125 |
| 2 | 0.25 |
| 3 | 0.375 |
| 4 | 0.5 |
| 5 | 0.625 |
| 6 | 0.75 |
| 7 | 0.875 |
| 8 | 1 |
| 9 | 1.125 |
| 10 | 1.25 |
| 12 | 1.5 |
| 15 | 1.875 |
| 18 | 2.25 |
| 20 | 2.5 |
| 24 | 3 |
| 30 | 3.75 |
| 36 | 4.5 |
| 40 | 5 |
| 48 | 6 |
| 60 | 7.5 |
Mounjaro 10mg
| מונג’רו 10mg | |
| קליק | מינון |
| 1 | 0.1667 |
| 2 | 0.3333 |
| 3 | 0.5 |
| 4 | 0.6667 |
| 5 | 0.8333 |
| 6 | 1 |
| 7 | 1.1667 |
| 8 | 1.3333 |
| 9 | 1.5 |
| 10 | 1.6667 |
| 12 | 2 |
| 15 | 2.5 |
| 18 | 3 |
| 20 | 3.3333 |
| 24 | 4 |
| 30 | 5 |
| 36 | 6 |
| 40 | 6.6667 |
| 48 | 8 |
| 60 | 10 |
Mounjaro 12.5mg
| מונג’רו 12.5mg | |
| קליק | מינון |
| 1 | 0.2083 |
| 2 | 0.4167 |
| 3 | 0.625 |
| 4 | 0.8333 |
| 5 | 1.0417 |
| 6 | 1.25 |
| 7 | 1.4583 |
| 8 | 1.6667 |
| 9 | 1.875 |
| 10 | 2.0833 |
| 12 | 2.5 |
| 15 | 3.125 |
| 18 | 3.75 |
| 20 | 4.1667 |
| 24 | 5 |
| 30 | 6.25 |
| 36 | 7.5 |
| 40 | 8.3333 |
| 48 | 10 |
| 60 | 12.5 |
Frequently Asked Questions (FAQ)
At the start of treatment, your doctor will determine the dosage weekly. Usually, the dosage is gradually increased based on your rate of weight loss until the optimal dosage is achieved. Patients typically remain at this optimal dosage until the treatment concludes.
It's preferable to take Rybelsus at the same time each day.
Side effects may include nausea, vomiting, diarrhea or constipation, and hypoglycemia, although most of these are mild and typically subside within several days to a few weeks.
Other possible side effects include indigestion (gas, hiccups, belching), stomach inflammation or pain, heartburn, dry mouth, changes in taste, gallstones, dizziness, rapid heartbeat, fatigue, insomnia, and changes in vision.
It's important to remember that your doctor, particularly one specializing in obesity treatment, can provide guidance on how to significantly reduce or even prevent medication side effects. Dynamic and real-time adjustments to the medication, including dosage changes and careful monitoring of interactions with other medications, can improve adherence and significantly reduce treatment dropout rates.
Rare side effects include severe allergic reactions (anaphylaxis), decreased kidney function or acute kidney failure, and elevated pancreatic enzyme levels.
Rybelsus is not recommended for people with severe digestive system issues, including gastroparesis or inflammatory bowel diseases. It may also increase the risk of thyroid problems, including malignancies. Additionally, individuals with conditions that heighten the risk of pancreatitis should exercise caution and require medical monitoring during treatment. Patients taking glimepiride or glyburide might need their dosages adjusted by their physician to avoid a sharp drop in blood sugar levels (hypoglycemia).
This medication is not included in the national health basket.
The information on this page does not replace medical consultation or serve as a basis for diagnosis. For detailed information regarding the medication, please refer to the patient information leaflet as approved by the Ministry of Health. For any additional questions, please consult your healthcare provider or pharmacist.